The UK's contribution to cancer control in low-income and middle-income countries.


Journal

The Lancet. Oncology
ISSN: 1474-5488
Titre abrégé: Lancet Oncol
Pays: England
ID NLM: 100957246

Informations de publication

Date de publication:
09 2021
Historique:
received: 28 03 2021
revised: 04 06 2021
accepted: 17 06 2021
pubmed: 4 9 2021
medline: 22 9 2021
entrez: 3 9 2021
Statut: ppublish

Résumé

Cancer mortality rates in low-income and middle-income countries (LMICs) are unacceptably high, requiring both collaborative global effort and in-country solutions. Experience has shown that working together in policy, clinical practice, education, training, and research leads to bidirectional benefit for LMICs and high-income countries. For over 60 years, the UK National Health Service has benefited from recruitment from LMICs, providing the UK with a rich diaspora of trained health-care professionals with links to LMICs. A grassroots drive to engage with partners in LMICs within the UK has grown from the National Health Service, UK academia, and other organisations. This drive has generated a model that rests on two structures: London Global Cancer Week and the UK Global Cancer Network, providing a high-value foundation for international discussion and collaboration. Starting with a historical perspective, this Series paper describes the UK landscape and offers a potential plan for the future UK's contribution to global cancer control. We also discuss the opportunities and challenges facing UK partnerships with LMICs in cancer control. The UK should harness the skills, insights, and political will from all partners to make real progress.

Identifiants

pubmed: 34478677
pii: S1470-2045(21)00380-6
doi: 10.1016/S1470-2045(21)00380-6
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e410-e418

Subventions

Organisme : Medical Research Council
ID : MR/P025420/1
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests We declare no competing interests.

Auteurs

Susannah Stanway (S)

UK Global Cancer Network, Manchester, UK. Electronic address: susannahstanway@gmail.com.

Mark Lodge (M)

UK Global Cancer Network, Manchester, UK; International Network for Cancer Treatment and Research, Oxford, UK.

Richard Sullivan (R)

Institute of Cancer Policy, King's College London, London, UK.

Kim Diprose (K)

UK Global Cancer Network, Manchester, UK.

Annie M Young (AM)

UK Global Cancer Network, Manchester, UK; Warwick Medical School, University of Warwick, Coventry, UK.

Nigel Crisp (N)

House of Lords, Houses of Parliament, London, UK.

Philippa Lewis (P)

Department of Clinical Oncology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

Tim Eden (T)

World Child Cancer, London, UK; School of Medical Sciences, University of Manchester, Manchester, UK.

Ajay Aggarwal (A)

Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK.

Amanda Nadin (A)

UK Global Cancer Network, Manchester, UK.

Frank Chinegwundoh (F)

Department of Surgery, Barts Health NHS Trust, London, UK.

Bhawna Sirohi (B)

Apollo Proton Cancer Centre, Chennai, India.

Ged Byrne (G)

Health Education England Global Engagement, London, UK; Department of Surgery, Manchester NHS Foundation Trust, Manchester, UK.

Richard Cowan (R)

UK Global Cancer Network, Manchester, UK; School of Medical Sciences, University of Manchester, Manchester, UK; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH